PHARMARON BEIJING CO., LTD. Funds and ETFs Pharmaron Beijing Co., Ltd. Hong Kong S.E.
Equities
3759
CNE100003PG4
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.83 HKD | +2.50% |
|
-4.00% | -37.86% |
ETFs positioned on Pharmaron Beijing Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.55% | 4 M€ | -27.92% | ||
| 0.57% | 2 M€ | -18.79% | - | |
| 0.26% | 3 M€ | +0.10% | - | |
| 0.09% | 2 M€ | -.--% | ||
| 0.03% | 7 M€ | -.--% | - | |
| 0.03% | 35 M€ | -5.85% | - | |
| 0.01% | 454 M€ | +4.02% | - | |
| 0.01% | 2,867 M€ | +5.89% | - | |
| 0.01% | 153 M€ | +3.74% | - | |
| 0.01% | 112 M€ | +4.61% | - | |
| 0.00% | 32 M€ | +6.87% | - | |
| 0.00% | 391 M€ | +7.63% | - | |
| 0.00% | 34 M€ | +7.50% | - | |
| 0.00% | 39 M€ | +5.00% | - | |
| 0.00% | 306 M€ | +5.07% | - | |
| 0.00% | 17 M€ | +2.42% | - | |
| 0.00% | 105 M€ | +2.97% | - | |
| 0.00% | 34 M€ | +3.86% | - | |
| 0.00% | 7 M€ | +5.36% | - | |
| 0.00% | 15 M€ | +13.60% | ||
| 0.00% | 8 M€ | +0.25% | - | |
| 0.00% | 54 M€ | +0.47% | - |
Pharmaron Beijing Co. is specialised in the research, development and manufacturing of small molecule drugs, cell therapies and gene therapies. Net sales break down by activity as follows:
- laboratory services (61.3%);
- development and production of chemical processes and formulations (23.5%);
- clinical research services (12.8%);
- other (2.4%);
Net sales are distributed geographically as follows: China (17.1%), Asia (2.6%), North America (64.2%), Europe (15.6%) and other (0.5%).
Calendar
2024-06-06
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
20.64
CNY
Average target price
24.15
CNY
Spread / Average Target
+16.99%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +43.36% | 54.63B | |
| -5.31% | 39.92B | |
| +14.75% | 26.86B | |
| -12.56% | 26.22B | |
| -22.45% | 18.78B | |
| +25.12% | 12.21B | |
| +0.04% | 12.16B | |
| +26.04% | 11.94B | |
| -11.83% | 10.74B |
- Stock Market
- Equities
- 300759 Stock
- 3759 Stock
- Funds and ETFs Pharmaron Beijing Co., Ltd.
